Enliven Therapeutics Inc (ELVN)

07:10 AM

Can Enliven Therapeutics Inc. stock deliver surprise earnings beatTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - Newser

07:10 AM

Dec 03, 2025

Wall Street Analysts Believe Enliven Therapeutics, Inc. (ELVN) Could Rally 101.26%: Here's is How to Trade - sharewise.com

Dec 03, 2025

Dec 03, 2025

Ready to Jump After Recent Trade: Enliven Therapeutics Inc (ELVN) - Setenews

Dec 03, 2025

Dec 03, 2025

Will Enliven Therapeutics Inc. stock keep outperforming rivals2025 Price Targets & Long-Term Capital Growth Strategies - Newser

Dec 03, 2025

Dec 03, 2025

Is Enliven Therapeutics Inc. stock ready for breakout2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser

Dec 03, 2025

Dec 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Shares Down 8%Time to Sell? - MarketBeat

Dec 02, 2025

Dec 01, 2025

Geode Capital Management LLC Grows Position in Enliven Therapeutics, Inc. $ELVN - MarketBeat

Dec 01, 2025

Dec 01, 2025

Franklin Resources Inc. Has $8.63 Million Stock Holdings in Enliven Therapeutics, Inc. $ELVN - MarketBeat

Dec 01, 2025

Nov 29, 2025

Risks Report: Will Enliven Therapeutics Inc. stock benefit from AI adoption2025 Macro Impact & Smart Swing Trading Alerts - BỘ NỘI VỤ

Nov 29, 2025

Nov 29, 2025

Will Enliven Therapeutics Inc. stock gain from strong economy2025 Fundamental Recap & Weekly Breakout Watchlists - BỘ NỘI VỤ

Nov 29, 2025

Nov 29, 2025

Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect? - MSN

Nov 29, 2025

Nov 27, 2025

(ELVN) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Nov 27, 2025

Nov 26, 2025

Enliven Therapeutics Inc (ELVN) is looking forward to a strong quarter - Setenews

Nov 26, 2025

Nov 25, 2025

Enliven Therapeutics targets CML drug resistance breakthrough - Traders Union

Nov 25, 2025

Nov 21, 2025

Enliven Therapeutics Insider Sold Shares Worth $279,155, According to a Recent SEC Filing - MarketScreener

Nov 21, 2025

Nov 21, 2025

Officer Lyssikatos Sells 12,500 ($279.2K) Of Enliven Therapeutics Inc [ELVN] - TradingView

Nov 21, 2025

Nov 21, 2025

[Form 4] Enliven Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025

Nov 21, 2025

Will Enliven Therapeutics Inc. stock outperform international peersWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

How Enliven Therapeutics Inc. stock reacts to Fed rate cutsGlobal Markets & Daily Technical Forecast Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Why Enliven Therapeutics Inc. stock is favored by pension fundsWall Street Watch & Low Drawdown Investment Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

What hedge fund activity signals for Enliven Therapeutics Inc. stock2025 Market Outlook & Weekly Top Gainers Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Is Enliven Therapeutics Inc. stock positioned well for digital economyMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Is Enliven Therapeutics Inc. stock a contrarian buy2025 Investor Takeaways & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Enliven Therapeutics CEO Kintz sells $272k in shares By Investing.com - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

CEO Kintz Sells 12,500 ($272.7K) Of Enliven Therapeutics Inc [ELVN] - TradingView

Nov 19, 2025

Nov 19, 2025

Shareholder Lyssikatos Revocable Trust 12/15/11 Files To Sell 12,500 Of Enliven Therapeutics Inc [ELVN] - TradingView

Nov 19, 2025

Nov 19, 2025

What analyst consensus says on Enliven Therapeutics Inc. stockJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Enliven Therapeutics Inc (ELVN) can make a big difference with a little luck - Setenews

Nov 18, 2025

Nov 18, 2025

Enliven Therapeutics: Notable Early Signals, But Too Many Assumptions To Justify A Buy - Seeking Alpha

Nov 18, 2025